Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
71 hedge funds and large institutions have $661M invested in Zymergen Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 21 increasing their positions, 17 reducing their positions, and 25 closing their positions.
24% more repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 17
12% less funds holding
Funds holding: 81 → 71 (-10)
18% less call options, than puts
Call options by funds: $7.79M | Put options by funds: $9.46M
32% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 25
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
68% less capital invested
Capital invested by funds: $2.09B → $661M (-$1.43B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$57M |
| 2 |
JP Morgan Chase
New York
|
+$40.3M |
| 3 |
ACG
Anchorage Capital Group
New York
|
+$24.6M |
| 4 |
BG
Bollard Group
Boston,
Massachusetts
|
+$21.5M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$13.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BAMCO Inc
New York
|
-$107M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$104M |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$60.9M |
| 4 |
Janus Henderson Group
London,
|
-$40.3M |
| 5 |
PA
Perceptive Advisors
New York
|
-$15.9M |
ZY Hedge Fund Activity: Q3 2021 in Review
71 of the 5,728 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q3 2021, worth a combined $661M — down 68% from $2.09B a quarter earlier.
Sellers outnumbered buyers: 25 funds closed out of ZY and 17 opened new positions — a net loss of 8 holders — while 17 trimmed existing stakes and 21 added.
The largest buyer was ARK Investment Management, adding an estimated $57M. The largest seller was BAMCO Inc, exiting entirely with an estimated $107M sold.
- 71 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q3 2021, down from 81 in Q2 2021.
- Funds reported $661M of Zymergen Inc. Common Stock stock for Q3 2021, down 68% quarter-over-quarter.
- 17 funds opened new Zymergen Inc. Common Stock positions in Q3 2021 and 25 closed out, a net change of -8 holders.
- The largest Zymergen Inc. Common Stock buyer in Q3 2021 was ARK Investment Management, an estimated $57M added.
- The largest Zymergen Inc. Common Stock seller in Q3 2021 was BAMCO Inc, an estimated $107M sold.
Based on aggregated 13F filings for Q3 2021.